Hua Yu

发表

PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.

J. Hecht, G. Fasola, J. Canon, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PEAK (study 20070509): A randomized phase II study of mFOLFOX6 with either panitumumab (pmab) or bevacizumab (bev) as first-line treatment (tx) in patients (pts) with unresectable wild‑type (WT) KRAS metastatic colorectal cancer (mCRC).

G. Fasola, J. Canon, F. Rivera, 2013 .

Analysis of KRAS/NRAS mutations in PEAK: A randomized phase II study of FOLFOX6 plus panitumumab (pmab) or bevacizumab (bev) as first-line treatment (tx) for wild-type (WT) KRAS (exon 2) metastatic colorectal cancer (mCRC).

G. Fasola, J. Canon, F. Rivera, 2013 .

The A10389G polymorphism of ND3 gene and breast cancer: A meta-analysis.

Hongwei Wang, Q. Wang, Linggen Gao, 2013, Biomedical reports.

Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).

F. Lordick, C. Punt, M. Ducreux, 2014 .

Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

Marc Peeters, Hua Yu, Gregory Wilson, 2015, Clinical Cancer Research.

Diabetes increases the risk of meningioma: A systematic review and meta-analysis of observational studies.

Juan Li, W. Zhong, Hua Yu, 2021, Cancer epidemiology.

Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis

M. Braddock, M. Zheng, K. Shi, 2015, Oncotarget.

miRNA-1284 inhibits cell growth and induces apoptosis of lung cancer cells

Jie Li, Hai-Rong Jin, Jian Tang, 2017, Molecular medicine reports.

The clinicopathological and prognostic role of thrombocytosis in patients with cancer: A meta-analysis.

Xiaojing Zhang, Hua Yu, Jianqing Zhu, 2017, Oncology letters.

The HLA-DQB1 gene polymorphisms associated with cervical cancer risk: A meta-analysis.

Xiaojing Zhang, Fangfang Wang, Hua Yu, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effects of exercise training on patients with lung cancer who underwent lung resection: a meta-analysis

Jie Li, Peng Wang, Hai-Rong Jin, 2017, World Journal of Surgical Oncology.

Optimization of Early Antimicrobial Strategies for Lung Transplant Recipients Based on Metagenomic Next-Generation Sequencing

Yu Lei, Xiao B. Huang, Hua Yu, 2022, Frontiers in Microbiology.

Data and Analysis Considerations in Oncology Clinical Trials

Hua Yu, Bin Yao, Yining Ye, 2016 .